Jessica Lisa Littau

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

Justin S. Sanchez, Mark Ellisman, R. Sperling, 2022, Acta Neuropathologica.

Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease

R. Kalaria, Y. Quiroz, M. Glatzel, 2022, Brain pathology.

Distinct tau neuropathology and cellular profiles of an APOE3 Christchurch homozygote protected against autosomal dominant Alzheimer’s dementia

Justin S. Sanchez, Mark Ellisman, R. Sperling, 2022, Acta Neuropathologica.

The blood-brain barrier is dysregulated in COVID-19 and serves as a CNS entry route for SARS-CoV-2

F. Müller, A. Kannt, Yan Liang, 2021, Stem Cell Reports.

Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotection

G. P. Cardona-Gómez, Jorge Toledo, S. Härtel, 2022, Brain pathology.

Resilience to autosomal dominant Alzheimer’s disease in a Reelin-COLBOS heterozygous man

Justin S. Sanchez, Keith A. Johnson, R. Sperling, 2023, Nature Medicine.

Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection

F. Lopera, D. Sepulveda-Falla, M. Audouard, 2024, Neuron.